ADTRAN Holdings, Inc. Common Stock

Day range

$3.92 – $4.35

Open

$4.31

Prev close

$4.13

Volume

3.15M

Market cap

$329.24M

Shares out

81.5M

P/E

—

P/S

0.29

P/B

2.54

P/FCF

5.78

ROE

-17.7%

ROA

-2.0%

Debt/Equity

1.69

Div yield

0.00%

As of Nov 6, 2026

• Investor presentationNov 3, 2026

  Executives from ADTRAN will review the financial results via a live audio webcast on Tuesday, November 3, 2026, at 7:30 a.m. Central Time, or 2:30 p.m. Central European Time. A copy of the investor presentation provided in connection with that review is attached as Exhibit 99.2 and incorporated by reference herein.

• Director appointmentOct 29, 2026

  On October 27, 2026, the Board of Directors (the "Board") of ADTRAN Holdings, Inc. (the "Company"), upon the recommendation of the Board's Nominating and Corporate Governance Committee, voted unanimously to increase the size of the Board from seven (7) to eight (8) directors and to elect Christian Terlinde as a director, effective as of October 27, 2026 (the "Effective Date"). The Board has determined that Dr. Terlinde qualifies as an "independent director" under Nasdaq listing standards.

• Executive compensation changeAug 10, 2026

  Consistent with the terms of the Amendment, grants of time-based RSUs and long-term financial plan PSUs were issued to Dr. Glingener on August 10, as approved by the Compensation Committee. Finally, the Amendment provides that Dr. Glingener's total annual remuneration remains capped at €2,800,000.

• Investor presentationAug 4, 2026

  Executives from ADTRAN will review the financial results via a live audio webcast on Tuesday, August 4, 2026, at 7:30 a.m. Central Time, or 2:30 p.m. Central European Time. A copy of the investor presentation provided in connection with that review is attached as Exhibit 99.2 and incorporated by reference herein.

• Credit facilityJul 23, 2026

  Furthermore, the Credit Agreement requires that the Consolidated Senior Secured Net Leverage Ratio (as defined in the Credit Agreement) of the Company and its subsidiaries, tested on the last day of each fiscal quarter, not exceed 3.25 to 1.0, subject to certain exceptions. The Credit Agreement also requires that (a) the Consolidated Fixed Charge Coverage Ratio (as defined in the Credit Agreement) of the Company and its subsidiaries tested on the last day of each fiscal quarter not fall below 1.25 to 1.00 and (b) during a Springing Covenant Period (as defined in the Credit Agreement) the Liquidity (as defined in the Credit Agreement) of the Company and its subsidiaries tested on the last day of each fiscal quarter not fall below $50.0 million.

Days to cover

7.2

Short interest

12.55M

Avg volume

1.73M

As of Oct 15, 2026 · reported to FINRA twice monthly.

• Can Viavi's U.S. Army Defense Testing Selection Propel Its Shares?
  positiveZacks Investment Research· Oct 14, 2026
• Can VIAV's New CF50 Strengthen Its Enterprise-Scale Testing Portfolio?
  positiveZacks Investment Research· Sep 30, 2026
• Ciena vs. ADTRAN: Which Optical Networking Stock is the Better Buy?
  positiveZacks Investment Research· Sep 22, 2026
• Why Is ADTRAN Holdings (ADTN) Down 14.7% Since Last Earnings Report?
  negativeZacks Investment Research· Sep 2, 2026
• ADTRAN Holdings, Inc. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
  negativeGlobeNewswire Inc.· Jul 27, 2026